Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Herpes Virus | Research article

Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania

Authors: Habakkuk Mwakyula Issakwisa, Gloria Reginald Mbwile, Godlove Fred Mbwanji, David Daniel Nassoro, Nyanda Elias Ntinginya, Anthony Ambikile Nsojo

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Despite the significant decline in the prevalence of HIV in Tanzania, the prevalence rates in Mbeya, Iringa, and Njombe regions are higher than the national average and have remained stable for years. The current stable HIV prevalence may be driven by factors such as a high incidence of sexually transmitted infections (STIs) and high-risk behaviours. In sub-Saharan Africa, it has previously been observed that up to 50% of HIV cases were attributed to herpes simplex type 2 (HSV-2) among low-risk populations. Because the proportion of sexually transmitted HSV-1 is rising, it is essential to study the interaction between HSV-1 and HIV infections.

Methods

We conducted a study in Mbeya region using the archived blood sera of participants from the recently completed EU-funded EMINI project. A specially designed questionnaire was used to obtain the social and demographic characteristics of the study participants in the database. We tested archived participants’ sera for herpes simplex virus type 1 using Virotech HSV-1 (gG1) IgG ELISA (Enzygnost, Behring, Germany). Univariate and multivariate Poisson regression models were used to identify factors associated with HSV-1.

Results

A total of 640 adults were randomly recruited after stratification by HIV status (318 were HIV positive), age, and sex. The overall seroprevalence of HSV-1 in the study population was 92.1%. The extrapolated seroprevalence estimate of herpes simplex virus type 1 in the general population was 95.0% (96.0% in males versus 94.0% in females). Males and females were equally affected by HSV-1. HSV-1 was less prevalent in HIV-positive individuals than in HIV-negative individuals.

Conclusion

People living with HIV were less likely to be HSV-1 seropositive. Further prospective studies are necessary to conclude a causal association.
Literature
2.
go back to reference Dodds JP. Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ. 2000;320(7248):1510–1.PubMedPubMedCentralCrossRef Dodds JP. Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ. 2000;320(7248):1510–1.PubMedPubMedCentralCrossRef
3.
go back to reference Do AN, Hanson DL, Dworkin MS, Jones JL. Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States. AIDS. 2001;15(9):1149–55.PubMedCrossRef Do AN, Hanson DL, Dworkin MS, Jones JL. Risk factors for and trends in gonorrhea incidence among persons infected with HIV in the United States. AIDS. 2001;15(9):1149–55.PubMedCrossRef
4.
go back to reference Bouhnik A-D. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health. 2002;56(5):349–53.PubMedPubMedCentralCrossRef Bouhnik A-D. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health. 2002;56(5):349–53.PubMedPubMedCentralCrossRef
5.
go back to reference Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 2019;17(1):57.PubMedPubMedCentralCrossRef Ayoub HH, Chemaitelly H, Abu-Raddad LJ. Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions. BMC Med. 2019;17(1):57.PubMedPubMedCentralCrossRef
6.
go back to reference Pereira VSS, Moizeis RNC, Fernandes TAAM, Araújo JMG, Meissner RV, Fernandes JV. Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):190–3.PubMedCrossRef Pereira VSS, Moizeis RNC, Fernandes TAAM, Araújo JMG, Meissner RV, Fernandes JV. Herpes simplex virus type 1 is the main cause of genital herpes in women of Natal, Brazil. Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):190–3.PubMedCrossRef
7.
go back to reference Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000;181(4):1454–7.PubMedCrossRef Lafferty WE, Downey L, Celum C, Wald A. Herpes simplex virus type 1 as a cause of genital herpes: impact on surveillance and prevention. J Infect Dis. 2000;181(4):1454–7.PubMedCrossRef
8.
go back to reference Lowhagen G-B. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect. 2000 Jun 1;76(3):179–82.PubMedPubMedCentralCrossRef Lowhagen G-B. First episodes of genital herpes in a Swedish STD population: a study of epidemiology and transmission by the use of herpes simplex virus (HSV) typing and specific serology. Sex Transm Infect. 2000 Jun 1;76(3):179–82.PubMedPubMedCentralCrossRef
9.
go back to reference Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Sex Transm Infect. 1993 Oct 1;69(5):381–3.CrossRef Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Sex Transm Infect. 1993 Oct 1;69(5):381–3.CrossRef
10.
go back to reference Mertz GJ, Rosenthal SL, Stanberry LR. Is Herpes Simplex Virus Type 1 (HSV-1) Now More Common than HSV-2 in First Episodes of Genital Herpes? Sex Transm Dis. 2003;30(10):801–2.PubMedCrossRef Mertz GJ, Rosenthal SL, Stanberry LR. Is Herpes Simplex Virus Type 1 (HSV-1) Now More Common than HSV-2 in First Episodes of Genital Herpes? Sex Transm Dis. 2003;30(10):801–2.PubMedCrossRef
11.
go back to reference Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20(1):73–83.PubMedCrossRef Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS. 2006;20(1):73–83.PubMedCrossRef
12.
go back to reference Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, et al. Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa. Bangsberg DR, editor. PLoS ONE. 2008;3(5):e2230.PubMedPubMedCentralCrossRef Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, et al. Genital Herpes Has Played a More Important Role than Any Other Sexually Transmitted Infection in Driving HIV Prevalence in Africa. Bangsberg DR, editor. PLoS ONE. 2008;3(5):e2230.PubMedPubMedCentralCrossRef
13.
go back to reference Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 Serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange farm, South Africa. J Infect Dis. 2009;199(7):958–64.PubMedPubMedCentralCrossRef Sobngwi-Tambekou J, Taljaard D, Lissouba P, Zarca K, Puren A, Lagarde E, et al. Effect of HSV-2 Serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange farm, South Africa. J Infect Dis. 2009;199(7):958–64.PubMedPubMedCentralCrossRef
14.
go back to reference Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes J IHMF. 2004;11(Suppl 3):130A–7A. Wald A. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes J IHMF. 2004;11(Suppl 3):130A–7A.
15.
go back to reference Schiffer JT, Gottlieb SL. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Vaccine. 2019 Nov;37(50):7363–71.PubMedCrossRef Schiffer JT, Gottlieb SL. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Vaccine. 2019 Nov;37(50):7363–71.PubMedCrossRef
16.
go back to reference Zuckerman R, Manji K, Matee M, Naburi H, Bisimba J, Martinez R, et al. HSV oropharyngeal shedding among HIV-infected children in Tanzania. Int J STD AIDS. 2015;26(7):456–61.PubMedCrossRef Zuckerman R, Manji K, Matee M, Naburi H, Bisimba J, Martinez R, et al. HSV oropharyngeal shedding among HIV-infected children in Tanzania. Int J STD AIDS. 2015;26(7):456–61.PubMedCrossRef
18.
go back to reference Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Inf Secur. 2006;52(5):367–73. Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. J Inf Secur. 2006;52(5):367–73.
19.
go back to reference Bünzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25–74 in 1992–93 : a population-based study. BMC Infect Dis. 2004;4(1):10.PubMedPubMedCentralCrossRef Bünzli D, Wietlisbach V, Barazzoni F, Sahli R, Meylan PR. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25–74 in 1992–93 : a population-based study. BMC Infect Dis. 2004;4(1):10.PubMedPubMedCentralCrossRef
20.
go back to reference Ibrahim AI, Kouwatli KM, Obeid MT. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med J. 2000;21(4):355–60.PubMed Ibrahim AI, Kouwatli KM, Obeid MT. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med J. 2000;21(4):355–60.PubMed
21.
go back to reference Wagner HU, Van Dyck E, Roggen E, Nunn AJ, Kamali A, Schmid DS, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS. 1994;5(5):332–7.PubMedCrossRef Wagner HU, Van Dyck E, Roggen E, Nunn AJ, Kamali A, Schmid DS, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS. 1994;5(5):332–7.PubMedCrossRef
22.
go back to reference Kasubi MJ, Nilsen A, Marsden HS, Bergstrom T, Langeland N, Haarr L. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol. 2006 Aug 1;44(8):2801–7.PubMedPubMedCentralCrossRef Kasubi MJ, Nilsen A, Marsden HS, Bergstrom T, Langeland N, Haarr L. Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol. 2006 Aug 1;44(8):2801–7.PubMedPubMedCentralCrossRef
23.
go back to reference Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect. 2006 Apr 1;82(2):164–8.PubMedPubMedCentralCrossRef Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect. 2006 Apr 1;82(2):164–8.PubMedPubMedCentralCrossRef
25.
go back to reference Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis. 2014 Feb 1;209(3):325–33.PubMedCrossRef Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis. 2014 Feb 1;209(3):325–33.PubMedCrossRef
26.
go back to reference Manavi K, Mcmillan A, Ogilvie M. Herpes simplex virus type 1 remains the principal cause of initial Anogenital herpes in Edinburgh, Scotland. Sex Transm Dis. 2004 May;31(5):322–4.PubMedCrossRef Manavi K, Mcmillan A, Ogilvie M. Herpes simplex virus type 1 remains the principal cause of initial Anogenital herpes in Edinburgh, Scotland. Sex Transm Dis. 2004 May;31(5):322–4.PubMedCrossRef
27.
28.
go back to reference Calistri A, Parolin C, Palù G. Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes: HIV and HSV-1 interactions in T lymphocytes. J Med Virol. 2003;70(1):163–70.PubMedCrossRef Calistri A, Parolin C, Palù G. Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes: HIV and HSV-1 interactions in T lymphocytes. J Med Virol. 2003;70(1):163–70.PubMedCrossRef
29.
go back to reference Polpitiya Arachchige S, Henke W, Kalamvoki M, Stephens EB. Analysis of herpes simplex type 1 gB, gD, and gH/gL on production of infectious HIV-1: HSV-1 gD restricts HIV-1 by exclusion of HIV-1 Env from maturing viral particles. Retrovirology. 2019 Dec;16(1):9.PubMedPubMedCentralCrossRef Polpitiya Arachchige S, Henke W, Kalamvoki M, Stephens EB. Analysis of herpes simplex type 1 gB, gD, and gH/gL on production of infectious HIV-1: HSV-1 gD restricts HIV-1 by exclusion of HIV-1 Env from maturing viral particles. Retrovirology. 2019 Dec;16(1):9.PubMedPubMedCentralCrossRef
30.
go back to reference Polpitiya Arachchige S, Henke W, Pramanik A, Kalamvoki M, Stephens EB. Analysis of select herpes simplex virus 1 (HSV-1) proteins for restriction of human immunodeficiency virus type 1 (HIV-1): HSV-1 gM protein potently restricts HIV-1 by preventing intracellular transport and processing of Env gp160. Sandri-Goldin RM, editor. J Virol. 2017;92(2):e01476–17.CrossRef Polpitiya Arachchige S, Henke W, Pramanik A, Kalamvoki M, Stephens EB. Analysis of select herpes simplex virus 1 (HSV-1) proteins for restriction of human immunodeficiency virus type 1 (HIV-1): HSV-1 gM protein potently restricts HIV-1 by preventing intracellular transport and processing of Env gp160. Sandri-Goldin RM, editor. J Virol. 2017;92(2):e01476–17.CrossRef
31.
go back to reference Spiegelman D, Easy SAS. Calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200.PubMedCrossRef Spiegelman D, Easy SAS. Calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005;162(3):199–200.PubMedCrossRef
Metadata
Title
Seroprevalence of herpes simplex virus type 1 among people living with HIV in Mbeya, Tanzania
Authors
Habakkuk Mwakyula Issakwisa
Gloria Reginald Mbwile
Godlove Fred Mbwanji
David Daniel Nassoro
Nyanda Elias Ntinginya
Anthony Ambikile Nsojo
Publication date
01-12-2020

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.